National Health Council
  • ABOUT
    • Our Members
    • Board of Directors
    • Staff
    • Our Support
    • Contact Us
  • Issue Areas
    • COVID-19
    • Health Equity, Diversity, & Inclusion
    • Reducing Health Costs
    • Health Care Reform
    • Value
    • Real-World Evidence
    • Patient Engagement
    • FDA Regulations
    • Medicaid Unwinding Resources
  • Resources
    • Member Resources
    • Fair-Market Value Calculator
    • Patient Experience Mapping
    • A Blueprint for Developing Patient-Centered Core Impact Sets (PC-CIS)
    • Meetings & Events
    • Newsroom
    • Letters & Comments
    • Research Briefs
    • Job Bank
  • Education
    • Real-World Evidence Classroom
    • Value Classroom
    • Patient-Focused Medical Product Development Series
    • Clinical Outcome Assessment Series
    • Health Literacy Series
    • Health Care Quality
    • Webinars
  • Blog
  • Membership
    • Our Members
    • Standards of Excellence
    • CAE Approved Provider
    • Join Us
  • Accessibility Tools

letters & comments

Notice of Benefit and Payment Parameters for 2021

03/02/2020 Read More

Office of Minority Health and Health Equity (OMHHE) Strategic Priorities Public Docket

02/28/2020 Read More

Patient-Focused Drug Development Guidance: Incorporating Clinical Outcome Assessments into Endpoints for Regulatory Decision-Making; Public Workshop

02/03/2020 Read More

Health and Human Services’ Transparency in Coverage Proposed Rule

01/30/2020 Read More

Medicare and State Healthcare Programs: Fraud and Abuse; Revisions To Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements

12/31/2019 Read More

Centers for Medicare & Medicaid Services’ (CMS’) Proposed Medicare Program Rule; Modernizing and Clarifying the Physician Self-Referral Regulations

12/31/2019 Read More

Patient-Focused Drug Development: Methods to Identify What Is Important to Patients; Draft Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders

12/18/2019 Read More

Congressional Efforts to Address Drug Pricing – Prescription Drug Pricing Reduction Act (PDPRA)

12/17/2019 Read More

Letter to Representatives DeGette & Upton on the “Cures 2.0” Initiative

12/16/2019 Read More
« Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next »
National Health Council
1730 M Street NW, Suite 650
Washington, DC 20036-4561
202-785-3910

ISSUE Areas

  • COVID-19
  • Health Equity, Diversity, & Inclusion
  • Reducing Health Costs
  • Health Care Reform
  • Value
  • Real-World Evidence
  • Patient Engagement
  • FDA Regulations
  • Medicaid Unwinding Resources

Blog

  • Putting Patients First Blog

Resources

  • Member Resources
  • Fair-Market Value Calculator
  • Meetings & Events
  • Newsroom
  • Letters & Comments
  • Job Bank

ABOUT

  • Board of Directors
  • Staff
  • Our Support
  • Contact Us

Education

  • Real-World Evidence Classroom
  • Value Classroom
  • PFMPD Series
  • Clinical Outcome Assessment Series
  • Health Literacy Series
  • Health Care Quality
  • Webinars

Membership

  • Standards of Excellence
  • Join Us
1730 M Street NW, Suite 650
Washington, DC 20036-4561
202-785-3910

©2023 National Health Council. All Rights Reserved.